InvestorsHub Logo
Followers 33
Posts 2859
Boards Moderated 1
Alias Born 10/24/2015

Re: None

Wednesday, 06/24/2020 5:38:12 PM

Wednesday, June 24, 2020 5:38:12 PM

Post# of 1610
Skip to the 33:30 min mark https://aacr20vm2.onlineeventpro.freeman.com/live-stream/15337837/AACR-Cancer-Research-Institute-Lloyd-J-Old-Award-in-Cancer-Immunology

Pretty similar to the other presentations Dr. Rosenberg has given in the past, but he did state that the responses in patients with chemorefractory metastatic solid epithelial cancer treated with TIL were 2% (1/45), selected TIL 12% (2/17), and selected TIL plus Keytruda 24% (6/25).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IOVA News